(Corrects dateline to August 26) (Reuters) -Makers of weight-loss drugs are expected to rake in more than $150 billion in ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

Serena Williams says she has lost weight using GLP-1 medication. The drugs help manage blood sugar and promote weight loss, ...

GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that ...

In summary, decreased levels of circulating GLP-1 and GIP appear to be primarily responsible for the impaired ability of the type 2 diabetes patient to mount an effective postprandial insulin ...

Both GLP-1 and GIP are rapidly cleaved by dipeptidyl peptidase-4 (DPP-4). GLP-1 is a product of a precursor molecule called pre-proglucagon, a polypeptide which is split to produce many hormones ...

The incretin therapies, which start with GLP-1, and now I'll look at GLP-1 and GIP, for me foundationally changed our treatment of diabetes because they have the benefit of being potent agents ...

With an average HbA1c reduction of up to 2.4% and weight loss of up to 11.3 kg with the highest dose, the investigational GIP/GLP-1 dual agonist LY3298176 impresses in patients with type 2 diabetes.

In eagerly awaited results from a new study, the pharmaceutical company Eli Lilly reports that a pill its scientists ...

Adults with type 2 diabetes assigned a novel dual GIP/GLP-1 receptor agonist for 40 weeks experienced significant reductions in HbA1c and body weight compared with those assigned placebo ...

Even when GIP and GLP-1 agonists are prescribed for Type 2 diabetes, additional restrictions are usually placed on commercial insurance coverage—over 75% of the time for Mounjaro and over 83% of ...